世界の医療・医薬品産業レポート

TOP  >  医療機器レポート  >  ENTデバイス  >  聴力インプラント - 医療機器パイプライン評価 2018年

聴力インプラント - 医療機器パイプライン評価 2018年
Hearing Implants - Medical Devices Pipeline Assessment, 2018

レポートタイトル 聴力インプラント - 医療機器パイプライン評価 2018年
出版社名 GlobalData
発刊日 2018-04-01
体裁 PDF / 89 ページ
シングルユーザ価格 US$ 2,500
レポート分類 医療機器レポート
地域 グローバル
領域 ENTデバイス
疾患名 -
薬剤名 -
企業名 -
備考 ※ ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※ 本レポートは、英文です。PDF(電子媒体)での納品となります。

レポート概要

このレポートは、世界の主要国における上記の医療機器開発についての包括的情報、さまざまな開発ステージでの比較分析、パイプライン製品開発における主要企業のレビュー、主な機器の治験段階、治験実施状況、治験開始および終了日、治験数などの情報を提供します。


注)本レポートの一部のセクションは、該当疾患におけるデータの可用性や妥当性に基づいて、削除または変更される場合があります。

目次

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Hearing Implants Overview 7
3 Products under Development 8
3.1 Hearing Implants - Pipeline Products by Stage of Development 8
3.2 Hearing Implants - Pipeline Products by Segment 9
3.3 Hearing Implants - Pipeline Products by Territory 10
3.4 Hearing Implants - Pipeline Products by Regulatory Path 11
3.5 Hearing Implants - Pipeline Products by Estimated Approval Date 12
3.6 Hearing Implants - Ongoing Clinical Trials 13
4 Hearing Implants - Pipeline Products under Development by Companies 14
4.1 Hearing Implants Companies - Pipeline Products by Stage of Development 14
4.2 Hearing Implants - Pipeline Products by Stage of Development 15
5 Hearing Implants Companies and Product Overview 16
5.1 Advanced Bionics LLC Company Overview 16
5.1.1 Advanced Bionics LLC Pipeline Products & Ongoing Clinical Trials Overview 16
5.2 Auritec Pharmaceuticals Inc Company Overview 17
5.2.1 Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 17
5.3 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview 18
5.3.1 Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 18
5.4 Cochlear Ltd Company Overview 19
5.4.1 Cochlear Ltd Pipeline Products & Ongoing Clinical Trials Overview 19
5.5 Hannover Medical School Company Overview 20
5.5.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 20
5.6 Huntington Medical Research Institutes Company Overview 21
5.6.1 Huntington Medical Research Institutes Pipeline Products & Ongoing Clinical Trials Overview 21
5.7 Labyrinth Devices Company Overview 22
5.7.1 Labyrinth Devices Pipeline Products & Ongoing Clinical Trials Overview 22
5.8 Nasseo, Inc. Company Overview 25
5.8.1 Nasseo, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
5.9 Northwestern University Company Overview 26
5.9.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 26
5.10 Oticon Medical AB Company Overview 27
5.10.1 Oticon Medical AB Pipeline Products & Ongoing Clinical Trials Overview 27
5.11 OtoKinetics Inc Company Overview 31
5.11.1 OtoKinetics Inc Pipeline Products & Ongoing Clinical Trials Overview 31
5.12 Ototronix, LLC Company Overview 33
5.12.1 Ototronix, LLC Pipeline Products & Ongoing Clinical Trials Overview 33
5.13 Sonova Holding AG Company Overview 34
5.13.1 Sonova Holding AG Pipeline Products & Ongoing Clinical Trials Overview 34
5.14 SpecialtyCare Inc Company Overview 36
5.14.1 SpecialtyCare Inc Pipeline Products & Ongoing Clinical Trials Overview 36
5.15 Tel Aviv Sourasky Medical Center Company Overview 37
5.15.1 Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 37
5.16 Trinity College Dublin Company Overview 38
5.16.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 38
5.17 University of Florida Company Overview 39
5.17.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 39
5.18 University of Michigan Company Overview 40
5.18.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 40
5.19 University of Michigan Pediatric Device Consortium Company Overview 41
5.19.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 41
5.20 University of Nottingham Company Overview 42
5.20.1 University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 42
5.21 University of Oklahoma Company Overview 43
5.21.1 University of Oklahoma Pipeline Products & Ongoing Clinical Trials Overview 43
5.22 University of South Florida Company Overview 44
5.22.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 44
5.23 University of Utah Company Overview 45
5.23.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview 45
5.24 University of Wisconsin Madison Company Overview 46
5.24.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 46
6 Hearing Implants- Recent Developments 47
6.1 Feb 27, 2018: Intersect ENT Reports Fourth Quarter and Full Year 2017 Results 47
6.2 Feb 27, 2018: Cochlear and The Royal Victorian Eye and Ear Hospital Open the Geelong Cochlear Care Centre - a first for Regional 48
6.3 Feb 21, 2018: Canadian initiative designed to improve hearing goes global 49
6.4 Feb 19, 2018: Elos Medtech - Year- end report for the period 1 January to 31 December, 2017 49
6.5 Feb 15, 2018: Elos Medtech builds up a strong platform within Dental Implant Systems 50
6.6 Feb 07, 2018: Double-digit growth in revenue and earnings - delivered on guidance 50
6.7 Feb 07, 2018: Knowles Reports Q4 & Full Year 2017 Financial Results and Provides Outlook for Q1 2018 52
6.8 Jan 22, 2018: CUHK and US Researchers Use Brain Scan to Predict Language Improvement after a Cochlear Implant in Deaf Children 53
6.9 Jan 08, 2018: Intersect ENT Reports Preliminary Q4 and Year 2017 Revenue 54
6.10 Dec 21, 2017: Advanced Bionics Sound Processors to Become Bluetooth Compatible With Any Cell Phone or TV, Based on Revolutionary New Chip Technology From Sonova 54
6.11 Dec 01, 2017: 3-D-Printed Prosthetic Implants Could Improve Treatment for Hearing Loss 56
6.12 Nov 27, 2017: Cochlear obtains FDA approval for first remote programming option for cochlear implants 57
6.13 Nov 14, 2017: Elos Medtech commits to the global orthopaedic market 58
6.14 Nov 13, 2017: First half results 2017/18: Sonova with strong growth across all businesses 58
6.15 Nov 02, 2017: Intersect ENT Reports Third Quarter 2017 Results 62
6.16 Oct 25, 2017: Elos Medtech: Interim report 1 January - 30 September, 2017 62
6.17 Oct 25, 2017: Knowles Reports Q3 2017 Financial Results and Provides Outlook for Q4 2017 64
6.18 Oct 03, 2017: Cochlear Introduces the World’s First Made for iPhone Cochlear Implant Sound Processor in the United Kingdom 64
6.19 Sep 01, 2017: Sonova appoints Arnd Kaldowski as new CEO and successor of Lukas Braunschweiler 65
6.20 Aug 25, 2017: Elos Medtech Interim Report January 1 - June 30, 2017 66
6.21 Aug 17, 2017: Cochlear Announces Financial Results for year Ended June 2017 67
6.22 Aug 03, 2017: Knowles Appoints Dr. Cheryl Shavers To Board of Directors 72
6.23 Aug 01, 2017: Intersect ENT Reports Second Quarter 2017 Results 72
6.24 Jul 31, 2017: Cochlear: Chief Executive Officer & President Transition Timeline Announced 73
6.25 Jul 26, 2017: Cochlear introduces the world’s first Made for iPhone cochlear implant sound processor 74
6.26 Jul 26, 2017: Knowles Reports Q2 2017 Financial Results and Provides Outlook for Q3 2017 76
6.27 Jul 20, 2017: Teresa L. Kline Joins Intersect ENT’s Board of Directors 76
6.28 Jul 13, 2017: Sonova announces change in the Management Board 77
6.29 Jun 29, 2017: Sonova announces change in the Management Board in Corporate HRM and Communications 78
6.30 May 16, 2017: Sonova reports substantial acceleration and strong fiscal year 78
6.31 May 02, 2017: Intersect ENT Reports First Quarter 2017 Results 82
6.32 Apr 26, 2017: Knowles reports Q1 2017 financial results and provides outlook for Q2 2017 83
6.33 Apr 26, 2017: Elos Medtech Interim report, 1 January - 31 March, 2017 83
6.34 Mar 10, 2017: Managing Director at Elos Medtech Tianjin steps down 85
7 Appendix 86
7.1 Methodology 86
7.2 About GlobalData 89
7.3 Contact Us 89
7.4 Disclaimer 89

1.2 List of Figures
Figure 1: Hearing Implants - Pipeline Products by Stage of Development 8
Figure 2: Hearing Implants - Pipeline Products by Segment 9
Figure 3: Hearing Implants - Pipeline Products by Territory 10
Figure 4: Hearing Implants - Pipeline Products by Regulatory Path 11
Figure 5: Hearing Implants - Pipeline Products by Estimated Approval Date 12
Figure 6: Hearing Implants - Ongoing Clinical Trials 13

1.1 List of Tables
Table 1: Hearing Implants - Pipeline Products by Stage of Development 8
Table 2: Hearing Implants - Pipeline Products by Segment 9
Table 3: Hearing Implants - Pipeline Products by Territory 10
Table 4: Hearing Implants - Pipeline Products by Regulatory Path 11
Table 5: Hearing Implants - Pipeline Products by Estimated Approval Date 12
Table 6: Hearing Implants - Ongoing Clinical Trials 13
Table 7: Hearing Implants Companies - Pipeline Products by Stage of Development 14
Table 8: Hearing Implants - Pipeline Products by Stage of Development 15
Table 9: Advanced Bionics LLC Pipeline Products & Ongoing Clinical Trials Overview 16
Table 10: Hires Fidelity 120 Pediatrics - Product Status 16
Table 11: Hires Fidelity 120 Pediatrics - Product Description 16
Table 12: Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 17
Table 13: Steroid Eluting Cochlear Implant - Product Status 17
Table 14: Steroid Eluting Cochlear Implant - Product Description 17
Table 15: Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 18
Table 16: Cerashield Coated Cochlear Inner Ear Implant - Product Status 18
Table 17: Cerashield Coated Cochlear Inner Ear Implant - Product Description 18
Table 18: Cochlear Ltd Pipeline Products & Ongoing Clinical Trials Overview 19
Table 19: Cochlear Nucleus 7 - Product Status 19
Table 20: Cochlear Nucleus 7 - Product Description 19
Table 21: Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 20
Table 22: Optical Cochlea Stimulator - Product Status 20
Table 23: Optical Cochlea Stimulator - Product Description 20
Table 24: Huntington Medical Research Institutes Pipeline Products & Ongoing Clinical Trials Overview 21
Table 25: Multisite Device - Product Status 21
Table 26: Multisite Device - Product Description 21
Table 27: Labyrinth Devices Pipeline Products & Ongoing Clinical Trials Overview 22
Table 28: MVI Vestibular Implant System - Product Status 22
Table 29: MVI Vestibular Implant System - Product Description 22
Table 30: Labyrinth Devices - Ongoing Clinical Trials Overview 23
Table 31: MVI Vestibular Implant System - First-in-human Early Feasibility Study of Safety, Tolerability and Efficacy for a Multichannel Vestibular Implant in Individuals with Bilateral Severe-to-profound Loss of Vestibular Sensation 24
Table 32: Nasseo, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
Table 33: Bone-Anchored Hearing Aid - Product Status 25
Table 34: Bone-Anchored Hearing Aid - Product Description 25
Table 35: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 26
Table 36: Cochlear Implant - Product Status 26
Table 37: Cochlear Implant - Product Description 26
Table 38: Oticon Medical AB Pipeline Products & Ongoing Clinical Trials Overview 27
Table 39: Neuro Zti Implant - Product Status 27
Table 40: Neuro Zti Implant - Product Description 27
Table 41: Next Generation Transcutaneous Bone Conduction Device - Product Status 27
Table 42: Next Generation Transcutaneous Bone Conduction Device - Product Description 28
Table 43: Oticon Medical AB - Ongoing Clinical Trials Overview 29
Table 44: Neuro Zti Implant - The Neuro Zti Cochlear Implant System Efficacy and Safety in Adults 30
Table 45: Neuro Zti Implant - Voice Guard Processing Evaluation in a Cohort of Subjects Implanted with the Neuro Cochlear Implant System 30
Table 46: OtoKinetics Inc Pipeline Products & Ongoing Clinical Trials Overview 31
Table 47: Krescendo I - Product Status 31
Table 48: Krescendo I - Product Description 31
Table 49: Krescendo II - Product Status 31
Table 50: Krescendo II - Product Description 32
Table 51: Ototronix, LLC Pipeline Products & Ongoing Clinical Trials Overview 33
Table 52: Dalhousie Hearing Device - Product Status 33
Table 53: Dalhousie Hearing Device - Product Description 33
Table 54: Sonova Holding AG Pipeline Products & Ongoing Clinical Trials Overview 34
Table 55: Ingenia - Product Status 34
Table 56: Ingenia - Product Description 34
Table 57: Next Generation Cochlear Implant - Product Status 35
Table 58: Next Generation Cochlear Implant - Product Description 35
Table 59: SpecialtyCare Inc Pipeline Products & Ongoing Clinical Trials Overview 36
Table 60: Miniature Middle Ear Implant - Product Status 36
Table 61: Miniature Middle Ear Implant - Product Description 36
Table 62: Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 37
Table 63: Implant Electrode Extender - Product Status 37
Table 64: Implant Electrode Extender - Product Description 37
Table 65: Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 38
Table 66: Closed-loop Cochlear Implant - Product Status 38
Table 67: Closed-loop Cochlear Implant - Product Description 38
Table 68: University of Florida Pipeline Products & Ongoing Clinical Trials Overview 39
Table 69: Adjustable Middle Ear Prosthesis Device - Product Status 39
Table 70: Adjustable Middle Ear Prosthesis Device - Product Description 39
Table 71: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 40
Table 72: Micro-Machined (MEMS) Acoustic Sensor - Product Status 40
Table 73: Micro-Machined (MEMS) Acoustic Sensor - Product Description 40
Table 74: University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 41
Table 75: Enhanced Cochlear Implant Device - Product Status 41
Table 76: Enhanced Cochlear Implant Device - Product Description 41
Table 77: University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 42
Table 78: Antibiotic Pellet - Product Status 42
Table 79: Antibiotic Pellet - Product Description 42
Table 80: University of Oklahoma Pipeline Products & Ongoing Clinical Trials Overview 43
Table 81: Totally Implantable Hearing System - Product Status 43
Table 82: Totally Implantable Hearing System - Product Description 43
Table 83: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 44
Table 84: Promontory Anchored Incus Replacement Prosthesis - Product Status 44
Table 85: Promontory Anchored Incus Replacement Prosthesis - Product Description 44
Table 86: University of Utah Pipeline Products & Ongoing Clinical Trials Overview 45
Table 87: Microphone Cochlear Implant - Product Status 45
Table 88: Microphone Cochlear Implant - Product Description 45
Table 89: University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 46
Table 90: Cochlear Implant - Product Status 46
Table 91: Cochlear Implant - Product Description 46
Table 92: Glossary 88
Loading....